For the fourth consecutive year, the commercial coatings group of PPG Industries' automotive refinish business will exhibit its extensive line of products at the annual U.S. Diesel Truckin' Nationals & Motorsports Spectacular, to be held ...
MeadWestvaco Corp. (MWV) has received a grant to provide its Medication Event Monitoring System (MEMS) to The Bill & Melinda Gates Foundation in projects to help prevent the spread of HIV/AIDS. MEMSCap Medication Event Monitoring System ...
Tags: Monitoring System, Packaging
Sovaldi (sofosbuvir) has been approved by the U.S. Food and Drug Administration to treat chronic infection with Hepatitis C. It's considered a breakthrough medication since it's the first such drug that does not require same-time ...
Tags: Sovaldi, chronic infection, Hepatitis C
Should people in danger of contracting HIV because they have risky sex take a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of debate on this question, a new international ...
Tags: HIV, medication
Gilead Sciences has received notice of compliance from Health Canada for its once-daily oral nucleotide analog polymerase inhibitor Sovaldi or sofosbuvir 400mg tablets for the treatment of chronic hepatitis C or CHC infection. Sovaldi is ...
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...
Tags: Gilead Sciences, Chronic Hepatitis
Janssen-Cilag (Janssen) has submitted a marketing authorization application to the European Medicines Agency (EMA) for the approval of a once-daily fixed-dose antiretroviral combination tablet of HIV-1 medicine darunavir with cobicistat. ...
Tags: European Marketing, HIV-1
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target. All initial product development ...
Tags: Adimab, Antibody-Based Therapeutic
Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...
Tags: Gilead, Sofosbuvir NDA
The European Commission has approved Gilead Sciences' Stribild for marketing as the single tablet regimen for HIV-1 treatment in all 27 countries of the European Union. Four of the Gilead's compounds elvitegravir 150mg, cobicistat 150mg, ...
EMC has announced new solutions and enhancements across its Documentum solution portfolio for the energy, life sciences and healthcare industries. At its flagship EMC World conference in Las Vegas, the company said the solutions are ...
Tags: Computer Products, software
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead Sciences' marketing authorization application (MAA) for stribild. The once-daily, single tablet regimen ...
Tags: Stribild drug, Medicines, Medicine
Biopharmaceutical company Pfizer has decided to discontinue the development of filibuvir, an experimental hepatitis C drug, following a strategic review and capital allocation. The drug, which is in mid-stage clinical testing, is facing ...
Tags: Pfizer, filibuvir drug, drug
Biopharmaceutical company Gilead Sciences has issued a voluntary recall of one lot of Vistide (cidofovir injection) at user level due to incidence of particulate matter in few vials. The recalled lot of the product was distributed to ...